The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 28, 2018

Filed:

Jan. 16, 2015
Applicants:

Laboratoire Francais Du Fractionnement ET Des Biotechnologies, Les Ulis, FR;

Etat Francais Represente Par Le Directeur Central Du Service DE Sante Des Armees, Armees, FR;

Inventors:

Christian Behrens, Vauhallan, FR;

Philippe Klein, Ales, FR;

Denis Hoguet, Saint Hilaire de Brethmas, FR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/12 (2006.01); G01N 33/569 (2006.01); A61K 47/10 (2017.01); A61K 39/40 (2006.01); A61K 47/68 (2017.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/1278 (2013.01); A61K 39/40 (2013.01); A61K 47/6835 (2017.08); G01N 33/56911 (2013.01); A61K 2039/505 (2013.01); A61K 2039/545 (2013.01); C07K 2317/21 (2013.01); C07K 2317/24 (2013.01); C07K 2317/41 (2013.01); C07K 2317/76 (2013.01); C07K 2317/92 (2013.01); G01N 2333/32 (2013.01);
Abstract

The present invention relates to a class-G immunoglobulin against the anthrax toxin protective antigen (PA), or one of the fragments of same, comprising at least: a variable heavy-chain region comprising an amino acid sequence represented by the sequence SEQ ID NO: 1, or comprising an amino acid sequence having at least 90% identity with the sequence SEQ ID NO: 1, and comprising the amino acids Leucine in position 51 and Glycine in position 67, and a variable light-chain region comprising an amino acid sequence represented by the sequence SEQ ID NO: 2, or comprising an amino acid sequence having at least 90% identity with the sequence SEQ ID NO: 2, and comprising a Leucine amino acid in position 55. The invention also relates to the uses of such an immunoglobulin.


Find Patent Forward Citations

Loading…